Nuzenio

Antitrypsin Deficiency

Antitrypsin Deficiency news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:20 GMT BEAM News | BEAM THERAPEUTICS INC (NASDAQ:BEAM) - ChartMillChartMill · Thu, 06 Aug 2026 07:00:00 GMT Closing the AATD Diagnostic Gap, With Sarah Tomashefski, MSN - HCPLiveHCPLive · Wed, 05 Aug 2026 14:10:14 GMT Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD) - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 11:00:00 GMT From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD - statnews.comstatnews.com · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 11:19:20 GMTGrifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency - The Manila Times

Thu, 06 Aug 2026 07:00:00 GMTBEAM News | BEAM THERAPEUTICS INC (NASDAQ:BEAM) - ChartMill

Wed, 05 Aug 2026 14:10:14 GMTClosing the AATD Diagnostic Gap, With Sarah Tomashefski, MSN - HCPLive

Tue, 04 Aug 2026 11:00:00 GMTBeam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD) - Yahoo Finance

Tue, 28 Jul 2026 07:00:00 GMTFrom ‘lost cause’ to gold rush: Biotechs swarm to cure AATD - statnews.com

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

Alpha4 live mentions BEAM4 live mentions AATD4 live mentions Grifols Announces Last2 live mentions Patient Last Visit2 live mentions SPARTA2 live mentions Phase2 live mentions Outcomes Study2 live mentions Prolastin2 live mentions Patients With Emphysema2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Antitrypsin Deficiency.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.